These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
231 related articles for article (PubMed ID: 34781266)
1. Survivorship Issues in Adult Patients With Histiocytic Neoplasms. O'Brien K; Dave R; Shekhar S; Hannah-Shmouni F; Comis LE; Solomon BI; Chen M; Gahl WA; FitzGibbon E; Gochuico BR; Estrada-Veras JI J Natl Compr Canc Netw; 2021 Nov; 19(11):1312-1318. PubMed ID: 34781266 [TBL] [Abstract][Full Text] [Related]
2. The Mayo Clinic Histiocytosis Working Group Consensus Statement for the Diagnosis and Evaluation of Adult Patients With Histiocytic Neoplasms: Erdheim-Chester Disease, Langerhans Cell Histiocytosis, and Rosai-Dorfman Disease. Goyal G; Young JR; Koster MJ; Tobin WO; Vassallo R; Ryu JH; Davidge-Pitts CJ; Hurtado MD; Ravindran A; Sartori Valinotti JC; Bennani NN; Shah MV; Rech KL; Go RS; Mayo Clin Proc; 2019 Oct; 94(10):2054-2071. PubMed ID: 31472931 [TBL] [Abstract][Full Text] [Related]
4. Comparison of neuroimaging features of histiocytic neoplasms with central nervous system involvement: a retrospective study of 121 adult patients. Fan X; Liu T; Zhang Z; Sun J; Niu N; Mao C; Wang F; Li J; Zhou D; Cao X; Jin Z; Feng F Eur Radiol; 2023 Nov; 33(11):8031-8042. PubMed ID: 37191919 [TBL] [Abstract][Full Text] [Related]
5. Highlights of the Management of Adult Histiocytic Disorders: Langerhans Cell Histiocytosis, Erdheim-Chester Disease, Rosai-Dorfman Disease, and Hemophagocytic Lymphohistiocytosis. Salama HA; Jazieh AR; Alhejazi AY; Absi A; Alshieban S; Alzahrani M; Alaskar A; Gmati G; Damlaj M; Abuelgasim KA; Alghamdi A; Alahmari B; Almugairi A; Alzahrani H; Bazarbachi A; Musa MOH; Goyal G Clin Lymphoma Myeloma Leuk; 2021 Jan; 21(1):e66-e75. PubMed ID: 32943371 [TBL] [Abstract][Full Text] [Related]
6. Uncommon histiocytic disorders: Rosai-Dorfman, juvenile xanthogranuloma, and Erdheim-Chester disease. Haroche J; Abla O Hematology Am Soc Hematol Educ Program; 2015; 2015():571-8. PubMed ID: 26637774 [TBL] [Abstract][Full Text] [Related]
16. Langerhans Cell Histiocytosis and Other Histiocytic Diseases of the Lung. DeMartino E; Go RS; Vassallo R Clin Chest Med; 2016 Sep; 37(3):421-30. PubMed ID: 27514589 [TBL] [Abstract][Full Text] [Related]
17. How I Diagnose Rosai-Dorfman Disease. Ravindran A; Rech KL Am J Clin Pathol; 2023 Jul; 160(1):1-10. PubMed ID: 37167084 [TBL] [Abstract][Full Text] [Related]
19. PU.1 is a useful nuclear marker to distinguish between histiocytosis and histiocyte-rich tumours. Ungureanu IA; Cohen-Aubart F; Héritier S; Haroche J; Donadieu J; Emile JF Histopathology; 2023 Aug; 83(2):320-325. PubMed ID: 37012662 [TBL] [Abstract][Full Text] [Related]
20. An unusual co-occurrence of Langerhans cell histiocytosis and Rosai-Dorfman disease: report of a case and review of the literature. Cohen-Barak E; Rozenman D; Schafer J; Krausz J; Dodiuk-Gad R; Gabriel H; Shani-Adir A Int J Dermatol; 2014 May; 53(5):558-63. PubMed ID: 23968608 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]